Sclerosing Cholangitis Epidemiology and Etiology

被引:0
作者
Konstantinos N. Lazaridis
机构
[1] Mayo Clinic College of Medicine,Center for Basic Research in Digestive Diseases, Division of Gastroenterology and Hepatology
来源
Journal of Gastrointestinal Surgery | 2008年 / 12卷
关键词
Cholestasis; Epidemiology; Pathogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Sclerosing cholangitis represents a spectrum of chronic biliary diseases that either has an unknown etiology (i.e., primary) or is caused by identifiable insults to the biliary tree (i.e., secondary). To date, the epidemiology of primary sclerosing cholangitis has been appraised; however, its etiology continues to be unclear. In contrast, the etiology of secondary sclerosing cholangitis is always known, but the epidemiology of this clinical entity is difficult to study.
引用
收藏
页码:417 / 419
页数:2
相关论文
共 80 条
  • [11] Strazzabosco M(2001)Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism Gastroenterology 120 1475-1482
  • [12] Larusso NF(2004)CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis Genes Immun 5 444-450
  • [13] Quigley EM(2004)Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1 J Hepatol 40 375-379
  • [14] LaRusso NF(1988)Prospective trial of penicillamine in primary sclerosing cholangitis Gastroenterology 95 1036-1042
  • [15] Ludwig J(1980)Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery Gut 21 851-854
  • [16] Bergquist A(1981)Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis or chronic ulcerative colitis Hepatology 1 632-640
  • [17] Lindberg G(2000)Serum autoantibodies in patients with primary sclerosing cholangitis J Hepatol 32 182-187
  • [18] Saarinen S(2003)Anti- Clin Exp Immunol 132 473-476
  • [19] Broome U(1999) antibodies and autoimmune liver diseases Lancet 354 43-44
  • [20] Chapman RW(2006)Sclerosing pancreato-cholangitis responsive to steroid therapy Am J Gastroenterol 101 2070-2075